Langerhans cell histiocytosis
Conditions
Interventions
None listed
Sponsors
Japan LCH Study Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who were diagnosed as LCH between 1996 and 2009, and have been followed up at the facility participating in the Japan LCH Study Group.
Exclusion criteria
Exclusion criteria: 1. Patients who are not proved to have LCH by histological examination 2. Patients who died within 3 years after diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of late complications over time | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factors for late complications Evaluation of clinical course of central nervous degenerative LCH | — |
Countries
Japan
Contacts
Public ContactAkira Morimoto
Jichi Medical University Pediatrics
Outcome results
None listed